Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Dexmedetomidine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 5 Breast Neoplasms 4 Thyroid Neoplasms 2 Chronic Pain 2 Agnosia 2 Urinary Bladder Neoplasms 1 Thrombosis 1 Sleep Initiation and Maintenance Disorders 1 Sigmoid Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Neuroinflammatory Diseases 1 Lung Injury 1 Inflammation 1 Hypoxia 1 Hyperthyroidism 1 Goiter 1 Elderly 1 Colorectal Neoplasms 1 Breast Cancer Female 1 Brain Neoplasms 1 Abdominal Cancer Surgeries 1

Interventions

Bupivacaine 2 pyrotinib 1 exemestane 1 abemaciclib 1 Tumor Burden 1 Thioctic Acid 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Ropivacaine 1 Radiotherapy 1 Radiofrequency Ablation 1 Mastectomy 1 Mammaplasty 1 Letrozole 1 Drug Therapy 1 Dexmedetomidine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡